Single-agent bevacizumab or lomustine versus a combination of bevacizumab plus lomustine in patients with recurrent glioblastoma (BELOB trial): a randomised controlled phase 2 tria... von Taal, Walter, MD, Oosterkamp, Hendrika M, MD, Walenkamp, Annemiek M E, MD, Dubbink, Hendrikus J, PhD, Beerepoot, Laurens V, MD, Hanse, Monique C J, MD, Buter, Jan, MD, Honkoop, Aafke H, MD, Boerman, Dolf, MD, de Vos, Filip Y F, MD, Dinjens, Winand N M, PhD, Enting, Roelien H, MD, Taphoorn, Martin J B, MD, van den Berkmortel, Franchette W P J, MD, Jansen, Rob L H, MD, Brandsma, Dieta, MD, Bromberg, Jacoline E C, MD, van Heuvel, Irene, Vernhout, René M, MSc, van der Holt, Bronno, PhD, van den Bent, Martin J, Prof

Volltext

Cognitive Rehabilitation in Patients With Gliomas: A Randomized, Controlled Trial von GEHRING, Karin, SITSKOORN, Margriet M, BOOGERD, Willem, VENINGA, Theo, TWIJNSTRA, Albert, BOERMAN, Dolf H, TAPHOORN, Martin J. B, AARONSON, Neil K, GUNDY, Chad M, SIKKES, Sietske A. M, KLEIN, Martin, POSTMA, Tjeerd J, VAN DEN BENT, Martin J, BEUTE, Guus N, ENTING, Roelien H, KAPPELLE, Arnoud C

Volltext

A randomized phase II study of bevacizumab versus bevacizumab plus lomustine versus lomustine single agent in recurrent glioblastoma: The Dutch BELOB study von Taal, Walter, Oosterkamp, Hendrika M, Walenkamp, Annemiek M.E., Beerepoot, Laurens Victor, Hanse, Monique, Buter, J., Honkoop, Aafke, Boerman, Dolf, De Vos, Filip Yves Francine Leon, Jansen, Rob L., van den Berkmortel, Franchette W.P.J., Brandsma, Dieta, Kros, Johan M, Bromberg, Jacoline E, van Heuvel, Irene, Smits, Marion, van der Holt, Bronno, Vernhout, Rene, Van Den Bent, Martin J.

Volltext

Lethal African trypanosomiasis in a traveler : MRI and neuropathology von BRAAKMAN, Hilde M. H, VAN DE MOLENGRAFT, Fred J. J. M, HUBERT, Wim W. A, BOERMAN, Dolf H

Volltext

Factors influencing the admission decision for complexity intervention units: A concept mapping approach von Caarls, Petra, van Schijndel, Maarten, van den Berk, Guido, Boenink, Annette, Boerman, Dolf, Lijmer, Jeroen, Honig, Adriaan, Terra, Maartje, Abel Thijs, Verwey, Bas, van Waarde, Jeroen, van Wijngaarden, Jeroen, van Busschbach, Jan

Volltext

AT-55FINAL ANALYSIS OF THE BELOB TRIAL (A RANDOMIZED PHASE II STUDY ON BEVACIZUMAB VERSUS BEVACIZUMAB PLUS LOMUSTINE VERSUS LOMUSTINE SINGLE AGENT IN RECURRENT GLIOBLASTOMA) AND FI... von Taal, Walter, Enting, Roelien, Taphoorn, Martin, Smits, Marion, Dubbink, Hendrikus, Beerepoot, Laurens, Hanse, Monique, Bralten, Linda, Oosterkamp, Hendrika, Walenkamp, Annemiek, Buter, Jan, Honkoop, Aafke, Boerman, Dolf, de Vos, Filip, Bromberg, Jacoline, Vernhout, Rene, van der Holt, Bronno, van den Bent, Martin

Volltext

AT-55 FINAL ANALYSIS OF THE BELOB TRIAL (A RANDOMIZED PHASE II STUDY ON BEVACIZUMAB VERSUS BEVACIZUMAB PLUS LOMUSTINE VERSUS LOMUSTINE SINGLE AGENT IN RECURRENT GLIOBLASTOMA) AND F... von Taal, Walter, Enting, Roelien, Taphoorn, Martin, Smits, Marion, Dubbink, Hendrikus, Beerepoot, Laurens, Hanse, Monique, Bralten, Linda, Oosterkamp, Hendrika, Walenkamp, Annemiek, Buter, Jan, Honkoop, Aafke, Boerman, Dolf, de Vos, Filip, Bromberg, Jacoline, Vernhout, Rene, van der Holt, Bronno, van den Bent, Martin

Volltext